Patent details

EP1945182 Title: FORMULATIONS OF TIPIFARNIB FOR INTRAVENOUS APPLICATION

Basic Information

Publication number:
EP1945182
PCT Application Number:
PCT/IB/2006/004228
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP068504638
PCT Publication Number:
WO/2007/110709
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMULATIONS OF TIPIFARNIB FOR INTRAVENOUS APPLICATION
French Title of Invention:
Préparation de tipifarnib pour l'application intraveineuse
German Title of Invention:
FORMULIERUNGEN VON TIPIFARNIB ZUR INTRAVENÖSEN VERABREICHUNG
SPC Number:

Dates

Filing date:
13/10/2006
Grant date:
28/07/2010
EP Publication Date:
28/07/2010
PCT Publication Date:
04/10/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/07/2008
EP B1 Publication Date:
28/07/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/10/2010
Expiration date:
13/10/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/10/2006
 
 

Name:
Janssen Pharmaceutica N.V.
Address:
Turnhoutseweg 30, 2340 Beerse, Belgium (BE)

Inventor

1

Name:
DRIES Willy, Albert, Maria, Carlo
Address:
Belgium (BE)

2

Name:
DE PORRE Peter Marie-Zoe Robert
Address:
Belgium (BE)

3

Name:
PALMER Peter, Albert
Address:
Belgium (BE)

4

Name:
FRANCOIS Marc, Karel, Jozef
Address:
Belgium (BE)

Priority

Priority Number:
726911 P
Priority Date:
14/10/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 9/08;
Filing date Document type Number of pages